Related Experiment Video
Updated: May 31, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
GBA-associated PD presents with nonmotor characteristics.
K Brockmann1, K Srulijes, A K Hauser
1Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research, University of Tu¨bingen, Tu¨bingen, Germany. Kathrin.Brockmann@uni-tuebingen.de
Neurology
|July 8, 2011
Summary
Glucocerebrosidase (GBA)-associated Parkinson disease (PD) patients exhibit more nonmotor symptoms like dementia and autonomic dysfunction. Transcranial sonography revealed distinct brainstem raphe echogenicity in GBA-PD compared to sporadic PD.
Area of Science:
- Neurology
- Genetics
- Medical Imaging
Background:
- Parkinson disease (PD) has genetic subtypes influencing clinical presentation.
- Glucocerebrosidase (GBA) gene mutations are linked to increased PD risk.
- Distinct characteristics of GBA-associated PD require further elucidation.
Purpose of the Study:
- To investigate unique motor, nonmotor, and imaging features in GBA-associated PD.
- To compare GBA-PD patients with sporadic PD (sPD) using transcranial sonography (TCS).
Main Methods:
- Twenty GBA-PD patients (heterozygous GBA mutations) and 20 sPD patients were assessed.
- Motor function evaluated using the Unified Parkinson's Disease Rating Scale-III.
- Nonmotor symptoms assessed via cognitive, neuropsychiatric, and autonomic function tests; TCS used for brain imaging.
Main Results:
- GBA-PD patients presented more frequently with dementia, neuropsychiatric disturbances, and autonomic dysfunction.
- GBA-PD cases were generally more severe than sPD.
- Reduced echogenicity of the brainstem raphe was more prevalent in GBA-PD patients via TCS.
Conclusions:
- Nonmotor symptoms are particularly prevalent in GBA-PD.
- Further research is essential to validate findings and understand GBA-PD pathogenesis.
- These insights may inform the development of targeted therapeutic strategies for GBA-PD.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...